Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Bristol Myers Squibb Company (BMY) had Free Cash Flow of $757.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$11.49B |
|
$2.68B |
|
$3.42B |
|
$8.07B |
|
$8.25B |
|
$3.24B |
|
-- |
|
$3.24B |
|
$3.24B |
|
$2.68B |
|
$2.68B |
|
$2.68B |
|
$2.68B |
|
$3.24B |
|
$3.83B |
|
2.04B |
|
2.05B |
|
$1.31 |
|
$1.31 |
|
| Balance Sheet Financials | |
$27.21B |
|
$7.66B |
|
$59.27B |
|
$86.48B |
|
$19.16B |
|
$42.15B |
|
$47.22B |
|
$66.37B |
|
$20.10B |
|
$-19.88B |
|
$20.10B |
|
2.04B |
|
| Cash Flow Statement Financials | |
$1.10B |
|
$-131.00M |
|
$-1.56B |
|
$10.22B |
|
$9.58B |
|
$-635.00M |
|
$146.00M |
|
$-1.28B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.42 |
|
-- |
|
-- |
|
0.68 |
|
2.21 |
|
70.22% |
|
28.19% |
|
28.19% |
|
-- |
|
28.20% |
|
23.30% |
|
|
Free Cash Flow |
$757.00M |
-- |
|
-- |
|
-- |
|
0.13 |
|
1.24 |
|
1.23 |
|
73.39 |
|
13.33% |
|
-13.47% |
|
3.10% |
|
4.30% |
|
$9.84 |
|
$0.37 |
|
$0.54 |
|